Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

miRNA Expression Profiles and Potential as Biomarkers in Nontuberculous Mycobacterial Pulmonary Disease.

Han SA, Jhun BW, Kim SY, Moon SM, Yang B, Kwon OJ, Daley CL, Shin SJ, Koh WJ.

Sci Rep. 2020 Feb 21;10(1):3178. doi: 10.1038/s41598-020-60132-0.

2.

Long-term follow-up of post-cardiac surgery Mycobacterium chimaera infections: A 5-center case series.

Julian KG, Crook T, Curley E, Appenheimer AB, Paules CI, Hasse B, Diekema DJ, Daley CL, de Sanctis J, Hellinger WC, Levin A, McSherry G, Freer C, Whitener CJ.

J Infect. 2020 Feb;80(2):197-203. doi: 10.1016/j.jinf.2019.12.007. Epub 2019 Dec 19.

PMID:
31863789
3.

Nontuberculosis mycobacteria infections: would there be pharmacodynamics without pharmacokinetics?

Kwak N, Dalcolmo MP, Daley CL, Eather G, Hasegawa N, Koh WJ, Thomson R, van Ingen J, Yim JJ.

Eur Respir J. 2019 Nov 28;54(5). pii: 1901806. doi: 10.1183/13993003.01806-2019. Print 2019 Nov. No abstract available.

PMID:
31780457
4.

Tuberculosis.

Lewinsohn DM, Daley CL.

Clin Chest Med. 2019 Dec;40(4):xi. doi: 10.1016/j.ccm.2019.08.004. No abstract available.

PMID:
31731991
5.

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Nahid P, Mase SR, Migliori GB, Sotgiu G, Bothamley GH, Brozek JL, Cattamanchi A, Cegielski JP, Chen L, Daley CL, Dalton TL, Duarte R, Fregonese F, Horsburgh CR Jr, Ahmad Khan F, Kheir F, Lan Z, Lardizabal A, Lauzardo M, Mangan JM, Marks SM, McKenna L, Menzies D, Mitnick CD, Nilsen DM, Parvez F, Peloquin CA, Raftery A, Schaaf HS, Shah NS, Starke JR, Wilson JW, Wortham JM, Chorba T, Seaworth B.

Am J Respir Crit Care Med. 2019 Nov 15;200(10):e93-e142. doi: 10.1164/rccm.201909-1874ST. Erratum in: Am J Respir Crit Care Med. 2020 Feb 15;201(4):500-501.

6.

International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass.

Hasse B, Hannan MM, Keller PM, Maurer FP, Sommerstein R, Mertz D, Wagner D, Fernández-Hidalgo N, Nomura J, Manfrin V, Bettex D, Hernandez Conte A, Durante-Mangoni E, Tang TH, Stuart RL, Lundgren J, Gordon S, Jarashow MC, Schreiber PW, Niemann S, Kohl TA, Daley CL, Stewardson AJ, Whitener CJ, Perkins K, Plachouras D, Lamagni T, Chand M, Freiberger T, Zweifel S, Sander P, Schulthess B, Scriven JE, Sax H, van Ingen J, Mestres CA, Diekema D, Brown-Elliott BA, Wallace RJ Jr, Baddour LM, Miro JM, Hoen B; M. chimaera ISCVID Investigators and; ISCVID Executive Committee, Athan E, Bayer A, Barsic B, Corey GR, Chu VH, Durack DT, Fortes CQ, Fowler V, Hoen B, Krachmer AW, Durante-Magnoni E, Miro JM, Wilson WR; Infectious Diseases Specialists; Hospital Epidemiologists; Microbiologists and Molecular Typing Specialists; Cardiac Surgeons/ Perfusionists/ Cardiologists; Ophthalmology; Anaesthesiologists; Public Health.

J Hosp Infect. 2020 Feb;104(2):214-235. doi: 10.1016/j.jhin.2019.10.009. Epub 2019 Nov 9.

7.

Efficacy and safety of tigecycline for Mycobacterium abscessus disease.

Kwon YS, Levin A, Kasperbauer SH, Huitt GA, Daley CL.

Respir Med. 2019 Oct - Nov;158:89-91. doi: 10.1016/j.rmed.2019.10.006. Epub 2019 Oct 8.

PMID:
31622813
8.

Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study.

Jhun BW, Moon SM, Jeon K, Kwon OJ, Yoo H, Carriere KC, Huh HJ, Lee NY, Shin SJ, Daley CL, Koh WJ.

Eur Respir J. 2020 Jan 2;55(1). pii: 1900798. doi: 10.1183/13993003.00798-2019. Print 2020 Jan.

PMID:
31619468
9.

Same meat, different gravy: ignore the new names of mycobacteria.

Tortoli E, Brown-Elliott BA, Chalmers JD, Cirillo DM, Daley CL, Emler S, Floto RA, Garcia MJ, Hoefsloot W, Koh WJ, Lange C, Loebinger M, Maurer FP, Morimoto K, Niemann S, Richter E, Turenne CY, Vasireddy R, Vasireddy S, Wagner D, Wallace RJ Jr, Wengenack N, van Ingen J.

Eur Respir J. 2019 Jul 11;54(1). pii: 1900795. doi: 10.1183/13993003.00795-2019. Print 2019 Jul. No abstract available.

PMID:
31296783
10.

Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.

Kwon YS, Daley CL, Koh WJ.

Expert Rev Respir Med. 2019 Sep;13(9):851-861. doi: 10.1080/17476348.2019.1638765. Epub 2019 Jul 8.

PMID:
31256694
11.

In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates.

Kim DH, Jhun BW, Moon SM, Kim SY, Jeon K, Kwon OJ, Huh HJ, Lee NY, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00665-19. doi: 10.1128/AAC.00665-19. Print 2019 Aug.

12.

GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.

Huh HJ, Kim SY, Shim HJ, Kim DH, Yoo IY, Kang OK, Ki CS, Shin SY, Jhun BW, Shin SJ, Daley CL, Koh WJ, Lee NY.

J Clin Microbiol. 2019 Jul 26;57(8). pii: e00516-19. doi: 10.1128/JCM.00516-19. Print 2019 Aug.

13.

Nontuberculous Mycobacterial Musculoskeletal Infection Cases from a Tertiary Referral Center, Colorado, USA.

Goldstein N, St Clair JB, Kasperbauer SH, Daley CL, Lindeque B.

Emerg Infect Dis. 2019 Jun;25(6):1075-1083. doi: 10.3201/eid2406.181041.

14.

Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.

Moon SM, Jhun BW, Baek SY, Kim S, Jeon K, Ko RE, Shin SH, Lee H, Kwon OJ, Huh HJ, Ki CS, Lee NY, Chung MJ, Lee KS, Shin SJ, Daley CL, Koh WJ.

Respir Med. 2019 May;151:1-7. doi: 10.1016/j.rmed.2019.03.014. Epub 2019 Mar 26.

PMID:
31047103
15.

Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis.

Henkle E, Curtis JR, Chen L, Chan B, Aksamit TR, Daley CL, Griffith DE, Winthrop KL.

Eur Respir J. 2019 Jul 18;54(1). pii: 1801896. doi: 10.1183/13993003.01896-2018. Print 2019 Jul.

PMID:
31000676
16.

The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research Registry.

Eden E, Choate R, Barker A, Addrizzo-Harris D, Aksamit TR, Daley CL, Daniels MLA, DiMango A, Fennelly K, Griffith DE, Johnson MM, Knowles MR, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Turino GM, Winthrop KL.

Chronic Obstr Pulm Dis. 2019 Apr 9;6(2):145-153. doi: 10.15326/jcopdf.6.2.2018.0156. Epub 2019 Apr 9.

17.

Similar characteristics of nontuberculous mycobacterial pulmonary disease in men and women.

Holt MR, Kasperbauer SH, Koelsch TL, Daley CL.

Eur Respir J. 2019 Jul 11;54(1). pii: 1900252. doi: 10.1183/13993003.00252-2019. Print 2019 Jul. No abstract available.

PMID:
30956208
18.

Species Distribution and Macrolide Susceptibility of Mycobacterium fortuitum Complex Clinical Isolates.

Kim SY, Moon SM, Jhun BW, Kwon OJ, Huh HJ, Lee NY, Lee SH, Shin SJ, Kasperbauer SH, Huitt GA, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02331-18. doi: 10.1128/AAC.02331-18. Print 2019 Jun.

19.

M ycobacterium abscessus pulmonary disease: individual patient data meta-analysis.

Kwak N, Dalcolmo MP, Daley CL, Eather G, Gayoso R, Hasegawa N, Jhun BW, Koh WJ, Namkoong H, Park J, Thomson R, van Ingen J, Zweijpfenning SMH, Yim JJ.

Eur Respir J. 2019 Jul 11;54(1). pii: 1801991. doi: 10.1183/13993003.01991-2018. Print 2019 Jul.

PMID:
30880280
20.

Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.

Moon SM, Choe J, Jhun BW, Jeon K, Kwon OJ, Huh HJ, Lee NY, Daley CL, Koh WJ.

Respir Med. 2019 Mar;148:37-42. doi: 10.1016/j.rmed.2019.01.012. Epub 2019 Jan 30.

PMID:
30827472
21.

Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease.

Moon SM, Jhun BW, Daley CL, Koh WJ.

Eur Respir J. 2019 May 23;53(5). pii: 1801636. doi: 10.1183/13993003.01636-2018. Print 2019 May. No abstract available.

PMID:
30819812
22.

Genomic Analysis of Cardiac Surgery-Associated Mycobacterium chimaera Infections, United States.

Hasan NA, Epperson LE, Lawsin A, Rodger RR, Perkins KM, Halpin AL, Perry KA, Moulton-Meissner H, Diekema DJ, Crist MB, Perz JF, Salfinger M, Daley CL, Strong M.

Emerg Infect Dis. 2019 Mar;25(3):559-563. doi: 10.3201/eid2503.181282.

23.

Genetic mutations in linezolid-resistant Mycobacterium avium complex and Mycobacterium abscessus clinical isolates.

Kim SY, Jhun BW, Moon SM, Jeon K, Kwon OJ, Huh HJ, Lee NY, Shin SJ, Daley CL, Koh WJ.

Diagn Microbiol Infect Dis. 2019 May;94(1):38-40. doi: 10.1016/j.diagmicrobio.2018.10.022. Epub 2018 Nov 30.

PMID:
30581010
24.

Treatment of Mycobacterium avium Complex Pulmonary Disease.

Kwon YS, Koh WJ, Daley CL.

Tuberc Respir Dis (Seoul). 2019 Jan;82(1):15-26. doi: 10.4046/trd.2018.0060. Review.

25.

Nontuberculous Mycobacterial Infections in Cystic Fibrosis.

Martiniano SL, Nick JA, Daley CL.

Thorac Surg Clin. 2019 Feb;29(1):95-108. doi: 10.1016/j.thorsurg.2018.09.008. Review.

PMID:
30454926
26.

The Global Fight Against Tuberculosis.

Daley CL.

Thorac Surg Clin. 2019 Feb;29(1):19-25. doi: 10.1016/j.thorsurg.2018.09.010. Review.

PMID:
30454918
27.

Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.

Daniel-Wayman S, Abate G, Barber DL, Bermudez LE, Coler RN, Cynamon MH, Daley CL, Davidson RM, Dick T, Floto RA, Henkle E, Holland SM, Jackson M, Lee RE, Nuermberger EL, Olivier KN, Ordway DJ, Prevots DR, Sacchettini JC, Salfinger M, Sassetti CM, Sizemore CF, Winthrop KL, Zelazny AM.

Am J Respir Crit Care Med. 2019 Apr 15;199(8):947-951. doi: 10.1164/rccm.201807-1273PP. No abstract available.

PMID:
30428263
28.

Mycobacterium chimaera Infections Related to the Heater-Cooler Unit Outbreak: A Guide to Diagnosis and Management.

Kasperbauer SH, Daley CL.

Clin Infect Dis. 2019 Mar 19;68(7):1244-1250. doi: 10.1093/cid/ciy789. Erratum in: Clin Infect Dis. 2019 Jun 18;69(1):195.

PMID:
30371755
29.

ALIS (Amikacin Liposome Inhalation Suspension): The Beginning of a Wonderland?

Daley CL, Olivier KN.

Am J Respir Crit Care Med. 2018 Oct 26. doi: 10.1164/rccm.201810-1901ED. [Epub ahead of print] No abstract available.

PMID:
30365392
30.

Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.

Shin SH, Jhun BW, Kim SY, Choe J, Jeon K, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01105-18. doi: 10.1128/AAC.01105-18. Print 2018 Oct.

31.

Management of Multidrug-Resistant Tuberculosis.

Daley CL, Caminero JA.

Semin Respir Crit Care Med. 2018 Jun;39(3):310-324. doi: 10.1055/s-0038-1661383. Epub 2018 Aug 2. Review.

PMID:
30071546
32.

Characteristics and Health-care Utilization History of Patients With Bronchiectasis in US Medicare Enrollees With Prescription Drug Plans, 2006 to 2014.

Henkle E, Chan B, Curtis JR, Aksamit TR, Daley CL, Winthrop KL.

Chest. 2018 Dec;154(6):1311-1320. doi: 10.1016/j.chest.2018.07.014. Epub 2018 Jul 25.

PMID:
30055168
33.

US Patient-Centered Research Priorities and Roadmap for Bronchiectasis.

Henkle E, Aksamit TR, Daley CL, Griffith DE, O'Donnell AE, Quittner AL, Malanga E, Prieto D, Leitman A, Winthrop KL.

Chest. 2018 Nov;154(5):1016-1023. doi: 10.1016/j.chest.2018.06.032. Epub 2018 Jul 5.

PMID:
29981718
34.

Mutations in gyrA and gyrB in Moxifloxacin-Resistant Mycobacterium avium Complex and Mycobacterium abscessus Complex Clinical Isolates.

Kim SY, Jhun BW, Moon SM, Shin SH, Jeon K, Kwon OJ, Yoo IY, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Suh GY, Koh WJ.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00527-18. doi: 10.1128/AAC.00527-18. Print 2018 Sep.

35.

Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease.

Jhun BW, Kim SY, Moon SM, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.

Am J Respir Crit Care Med. 2018 Nov 15;198(10):1322-1330. doi: 10.1164/rccm.201802-0321OC.

PMID:
29877739
36.

Mycobacterial biomaterials and resources for researchers.

Hazbón MH, Rigouts L, Schito M, Ezewudo M, Kudo T, Itoh T, Ohkuma M, Kiss K, Wu L, Ma J, Hamada M, Strong M, Salfinger M, Daley CL, Nick JA, Lee JS, Rastogi N, Couvin D, Hurtado-Ortiz R, Bizet C, Suresh A, Rodwell T, Albertini A, Lacourciere KA, Deheer-Graham A, Alexander S, Russell JE, Bradford R, Riojas MA.

Pathog Dis. 2018 Jun 1;76(4). doi: 10.1093/femspd/fty042. Review.

37.

Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease.

Jhun BW, Yang B, Moon SM, Lee H, Park HY, Jeon K, Kwon OJ, Ahn J, Moon IJ, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00011-18. doi: 10.1128/AAC.00011-18. Print 2018 Jul.

38.

Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement.

van Ingen J, Aksamit T, Andrejak C, Böttger EC, Cambau E, Daley CL, Griffith DE, Guglielmetti L, Holland SM, Huitt GA, Koh WJ, Lange C, Leitman P, Marras TK, Morimoto K, Olivier KN, Santin M, Stout JE, Thomson R, Tortoli E, Wallace RJ Jr, Winthrop KL, Wagner D; for NTM-NET.

Eur Respir J. 2018 Mar 22;51(3). pii: 1800170. doi: 10.1183/13993003.00170-2018. Print 2018 Mar. No abstract available.

39.

A Woman with a 15-Year History of Bronchiectasis and Recurrent Nontuberculous Mycobacterium Pulmonary Disease.

Hogan PE, Koelsch T, Daley CL, Kasperbauer SH.

Ann Am Thorac Soc. 2018 Mar;15(3):380-382. doi: 10.1513/AnnalsATS.201707-585CC. No abstract available.

PMID:
29493335
40.

The Prevalence and Significance of Staphylococcus aureus in Patients with Non-Cystic Fibrosis Bronchiectasis.

Metersky ML, Aksamit TR, Barker A, Choate R, Daley CL, Daniels LA, DiMango A, Eden E, Griffith D, Johnson M, Knowles M, O'Donnell AE, Olivier K, Salathe M, Thomashow B, Tino G, Turino G, Winthrop KL, Mannino D.

Ann Am Thorac Soc. 2018 Mar;15(3):365-370. doi: 10.1513/AnnalsATS.201706-426OC.

41.

Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease.

Choi H, Jhun BW, Kim SY, Kim DH, Lee H, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.

Diagn Microbiol Infect Dis. 2018 Apr;90(4):293-295. doi: 10.1016/j.diagmicrobio.2017.12.008. Epub 2017 Dec 16.

PMID:
29329759
42.

Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.

Jhun BW, Moon SM, Kim SY, Park HY, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Chung MJ, Lee KS, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01812-17. doi: 10.1128/AAC.01812-17. Print 2018 Feb.

43.

Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype.

Koh WJ, Moon SM, Kim SY, Woo MA, Kim S, Jhun BW, Park HY, Jeon K, Huh HJ, Ki CS, Lee NY, Chung MJ, Lee KS, Shin SJ, Daley CL, Kim H, Kwon OJ.

Eur Respir J. 2017 Sep 27;50(3). pii: 1602503. doi: 10.1183/13993003.02503-2016. Print 2017 Sep.

44.

Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease.

Choi H, Kim SY, Kim DH, Huh HJ, Ki CS, Lee NY, Lee SH, Shin S, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e01146-17. doi: 10.1128/AAC.01146-17. Print 2017 Oct.

45.

Frequency of untreated hypogammaglobulinemia in bronchiectasis.

Ruffner MA, Aksamit TR, Thomashow B, Choate R, DiMango A, Turino GM, O'Donnell AE, Johnson MM, Olivier KN, Fennelly K, Daley CL, Winthrop KL, Metersky ML, Salathe MA, Knowles MR, Daniels MLA, Noone PG, Tino G, Griffith DE, Sullivan KE.

Ann Allergy Asthma Immunol. 2017 Jul;119(1):83-85. doi: 10.1016/j.anai.2017.04.020. Epub 2017 May 20. No abstract available.

46.

Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection.

Martiniano SL, Wagner BD, Levin A, Nick JA, Sagel SD, Daley CL.

Chest. 2017 Oct;152(4):800-809. doi: 10.1016/j.chest.2017.04.175. Epub 2017 May 5.

PMID:
28483608
47.

Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry.

Henkle E, Aksamit TR, Barker AF, Curtis JR, Daley CL, Anne Daniels ML, DiMango A, Eden E, Fennelly K, Griffith DE, Johnson M, Knowles MR, Leitman A, Leitman P, Malanga E, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Prieto D, Salathe M, Thomashow B, Tino G, Turino G, Wisclenny S, Winthrop KL.

Chest. 2017 Dec;152(6):1120-1127. doi: 10.1016/j.chest.2017.04.167. Epub 2017 May 5.

48.

Mycobacterium avium Complex Disease.

Daley CL.

Microbiol Spectr. 2017 Apr;5(2). doi: 10.1128/microbiolspec.TNMI7-0045-2017. Review.

PMID:
28429679
49.

Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease.

Yang B, Jhun BW, Moon SM, Lee H, Park HY, Jeon K, Kim DH, Kim SY, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02052-16. doi: 10.1128/AAC.02052-16. Print 2017 Jun.

50.

Mycobacterium tuberculosis Infection among Asian Elephants in Captivity.

Simpson G, Zimmerman R, Shashkina E, Chen L, Richard M, Bradford CM, Dragoo GA, Saiers RL, Peloquin CA, Daley CL, Planet P, Narachenia A, Mathema B, Kreiswirth BN.

Emerg Infect Dis. 2017 Mar;23(3):513-516. doi: 10.3201/eid2303.160726. Erratum in: Emerg Infect Dis. 2017 Apr;23(4):724.

Supplemental Content

Loading ...
Support Center